Zinc sulphate in the treatment of cutaneous leishmaniasis: an in vitro and animal study.

This study was designed to evaluate the effectiveness of zinc sulphate both in vitro and in an animal model against both strains of old world cutaneous leishmaniasis. The in vitro sensitivities of promastigotes and axenic amastigotes of both Leishmania major and L. tropica to zinc sulphate was determined, the LD50 calculated and compared to the standard treatment for cutaneous leishmaniasis pentavalent antimony compounds. The results show that the two forms of both strains were sensitive to zinc sulphate and their respective LD50 were lower compared to the pentavalent antimony compound. Furthermore the sensitivities of the forms of both strains were tested using a simple slide method and compared to results of the standard method. To confirm this result, zinc sulphate was administered orally to mice infected with cutaneous leishmaniasis both therapeutically and prophylactically. Results showed that oral zinc sulphate was effective in both treatment and prophylaxis for cutaneous leishmaniasis. These results encourage the use of oral zinc sulphate in the treatment of cutaneous leishmaniasis clinically.

[1]  K. Sharquie,et al.  Treatment of Cutaneous Leishmaniasis by Direct Current Electrotherapy: The Baghdadin Device , 1998, The Journal of dermatology.

[2]  R. A. Najim,et al.  A comparative controlled trial of intralesionally‐administered zinc sulphate, hypertonic sodium chloride and pentavalent antimony compound against acute cutaneous leishmaniasis , 1997, Clinical and experimental dermatology.

[3]  K. Sharquie.  A New Intralesional Therapy of Cutaneous Leishmaniasis with Hypertonic Sodium Chloride Solution , 1994, The Journal of dermatology.

[4]  T. Khoja,et al.  INTRALESIONAL TREATMENT OF CUTANEOUS LEISHMANIASIS WITH SODIUM STIBOGLUCONATE ANTIMONY , 1993, International journal of dermatology.

[5]  M. Rassam,et al.  Axenic cultivation of amastigotes of Leishmania donovani and Leishmania major and their infectivity. , 1992, Annals of tropical medicine and parasitology.

[6]  P. Fraker,et al.  Zinc requirement for macrophage function: effect of zinc deficiency on uptake and killing of a protozoan parasite. , 1989, Immunology.

[7]  A. Chu,et al.  Intralesional therapy of cutaneous leishmaniasis with sodium stibogluconate antimony , 1988, The British journal of dermatology.

[8]  G. P. Jacobs,et al.  Topical chemotherapy of cutaneous Leishmaniasis. , 1988, Parasitology today.

[9]  M. J. Healy.  Estimating LD50s without a computer. , 1988, Parasitology today.

[10]  A. Bryceson,et al.  Therapy in man. , 1987 .

[11]  Y. Al-Gindan,et al.  Ketaconazole in Cutaneous Leishmaniasis: Results of a Pilot Study , 1986 .

[12]  A. Pan,et al.  Leishmania mexicana: comparative fine structure of amastigotes and promastigotes in vitro and in vivo. , 1986, Experimental parasitology.

[13]  R. Cousins.  Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin. , 1985, Physiological reviews.

[14]  A. Pan.  Leishmania mexicana: serial cultivation of intracellular stages in a cell-free medium. , 1984, Experimental parasitology.

[15]  M. Talaat,et al.  Cryosurgery in cutaneous leishmaniasis , 1982, The British journal of dermatology.

[16]  W. Peters,et al.  The experimental chemotherapy of leishmaniasis, VI. The development of rodent models for cutaneous infection with L. major and L. mexicana amazonensis. , 1980, Annals of tropical medicine and parasitology.

[17]  N. Chejanovsky,et al.  Selective inhibition of herpes simplex virus type 1 DNA polymerase by zinc ions. , 1978, Virology.

[18]  A. Prasad.  Zinc in human nutrition. , 1977, CRC critical reviews in clinical laboratory sciences.

[19]  Rahim Gf,et al.  Oriental sore in Iraq. , 1966 .

[20]  G. F. Rahim,et al.  Oriental sore in Iraq. , 1966, Bulletin of endemic diseases.

[21]  O. Theodor,et al.  The Identity of Leishmania tropica Wright, 1903, and Herpetomonas papatasii Adler, 1925. , 1926 .